Additive effects of human recombinant interleukin-11 and granulocyte colony-stimulating factor in experimental gram-negative sepsis

Blood

Volumn 93, Issue 10, 1999, Pages 3467-3472

  Opal, Steven M ^a   Jhung, Jhung W ^b   Keith Jr , James C ^b   Goldman, Samuel J ^b   Palardy, John E ^b   Parejo, Nicolas A ^b  

^a BROWN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; PLACEBO; RECOMBINANT INTERLEUKIN 11; SODIUM CHLORIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW SUPPRESSION; CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; GASTROINTESTINAL MUCOSA; GRAM NEGATIVE SEPSIS; HISTOPATHOLOGY; LEUKOCYTE COUNT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL RATE;

EID: 0033562671     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.10.3467.410k10_3467_3472     Document Type: Article

References (36)

1. Morstyn G, Foote N, Nelson S: Clinical benefits of improving host defenses with rHuG-CSF. Ciba Found Symp 206:78, 1997
2. Bobey N, Woodman RC: Neutropenic complication in advanced-stage non-Hodgkin's lymphoma: Implications for the use of prophylactic recombinant human granulocyte-colony stimulating factor (G-CSF). Clin Invest Med 21:63, 1998
3. Freedman MH: Safety of long-term administration of granulocyte colony-stimulating factor for severe chronic neutropenia. Curr Opin Hematol 4:217, 1997
4. Keith JC, Albert A, Sonis ST, Pfeiffer CJ, Schaub RG: Interleukin-11, a pleiotropic cytokine: Exiting new effects of IL-11 on gastrointestinal mucosal biology. Stem Cells 12: 79, 1994 (suppl)
5. Neben S, Turner K: The biology of interleukin-11. Stem Cells 11:156, 1993 (suppl 2)
6. Pettengell R, Gurney H, Radford JA, Deakin DP, James R, Wilkinson PM, Kane K, Bentley J, Crowther D: Granulocyte colony-stimulating factor to prevent dose-limitng neutropenia in non-Hodgkins lymphoma: A randomized controlled trial. Blood 80:1430, 1992
7. Crawford J, Ozer H, Stoller R, Johnson D, Lyman G, Tabbara I, Kris M, Grous J, Picozzi V, Rausch G, Smith R, Gradishar W, Yahanda A, Vincent M, Stewart M, Glaspy J: Reduction by granulocyte colony-stimulating factor of fever and neutropenia by chemotherapy in patients with small-cell lung cancer. N Engl J Med 325:164, 1991
8. Lundblad R, Mesland JM, Giercksky KE: Granulocyle colony-stimulating factor improves survival rate and reduces concentrations of bacteria, endotoxin, tumor necrosis factor, and endothelin-1 in fulminant intra-abdominal sepsis in rats. Crit Care Med 24:820, 1996
9. Weisbart RH, Golde DW, Clark SC, Wong GG, Gasson JC: Human granulocyte-macrophage stimulating factor is a neutrophil activator. Nature 314:361, 1985
10. Kitagawa S, Yuo A, Souza LM, Saito M, Muira Y,Takaku F: Recombinant human granulocyte colony-stimulating factor enhances superoxide release in human granulocytes by the chemotactic peptide. Biochem Biophys Res Commun 144:1143, 1987
11. Shirai R, Kadota J, Tomono K, Ogawa K, Lida K, Kawakami K, Kohno S: Protective effect of granulocyte colony-stimulating factor (G-CSF) in a granulocytopenic mouse model of Pseudomonas aeruginosa lung infection through enhanced phagocytosis and killing. Clin Exp Immunol 109:73, 1997
12. Du XX, Williams DA: Interleukin-11: A multifunctional growth factor derived from the hemalopoietic micro-environment. Blood 83:2023, 1994
13. Van Leuven F, Stas I, Hilliker C, Miyake Y, Bilinski P, Gossler A: Molecular cloning and characterization of the human interleukin-11 receptor a chain gene IL-11ra located on chromosome 9p 13. Genomics 31:65, 1996
14. Robb L, Li R, Nandurkar HH, Koentgen F, Begley CG: Infertility in female mice lacking the receptor for the interleukin-11 is due to defective uterine response to implantation. Nat Med 4:303, 1998
15. Nandurkar HH, Robb L, Tarlinton D, Barnett L, Köntgen F, Begley CG: Adult mice with targeted mutation of the interleukin-11 receptor (IL11Ra) display normal hematopoiesis. Blood 90:2148, 1997
16. Trepicchio W, Bozza M, Pednuit G, Dorner AJ: Recombinant human interleukin-11 attenuates the inflammatory response through down-regulation of pro-inflammatory cytokine release and nitric oxide production. J Immunol 157:3627, 1996
17. Chérel M, Sorel M, Lebeau B, Dubois S, Moreau J-F, Bataille R, Minivielle S, Jacques Y: Moelcular cloning of two isoforms of a receptor for the human hematopoietic cytokine interleukin-11. Blood 86:2534, 1995
18. Kaye JF: Clinical development of recombinant human interleukin-11 to treat chemotherapy-induced thrombocytopenia. Curr Opin Hematol 3:209, 1996
19. Tepler I, Elias L, Smith II JW, Hussein M, Rosen G, Chang AY-C, Moore JO, Gordon MS, Kuca B, Beach KJ, Loewy JW, Garnick MB, Kaye JA: A randomized placebo-controlled trial of human recombinant interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood 87:3607, 1996
20. Gordon MS, McCaskill-Stevens WJ, Battiato LA, Loewry J, Loesch D, Breeden E, Hoffman R, Beach KL, Kuca B, Kaye J, Sledge GW Jr: A phase 1 trial of recombinant human interleukin-11 (Neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy. Blood 87:3615, 1996
21. Orazi A, Du XX, Yang Z, Kashai M, Williams DA: Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation. Lab Invest 75:33, 1996
22. Potten CS: Interleukin-11 protects the clonogenic stem cells in murine small intestinal mucosa from impairment of their reproductive capacity by radiation. Int J Cancer 62:356, 1995
23. Du XX, Doerschuk CM, Orazi A, Williams DA: A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy. Blood 83:33, 1994
24. Opal SM, Jhung J, Keith JC Jr, Palardy JE, Parejo N, Schaub J: Human recombinant interleukin-11 in the treatment of immunocompromised animals with experimental Pseudomonas aeruginosa sepsis. J Infect Dis 178:1205, 1998
25. Cross AS, Opal SM, Sadoff JC, Gemski P: Choice of bacteria in animal models of sepsis. Infect Immun 61:2741, 1993
26. Opal SM, Keith JC Jr: Potential role of human interleukin-11 in bacterial sepsis, in Vincent J-L (ed): Yearbook of Intensive Care and Emergency Medicine. Berlin, Germany, Springer-Verlag, 1997, p 111
27. Misra BR, Ferranti TJ, Donnelly LH, Erickson JE, Schaub RG, Keith JC: Recombinant human interleukin-11 prevents hypotension in LPS-treated anaesthetized rabbits. J Endotoxin Res 3:297, 1996
28. Berton BL, Shortall J, Jackson JV: Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock model. Infect Immun 64:714, 1996
29. Trepicchio WL, Wang L, Bozza M, Domer AJ: IL-11 regulates macrophage effector function through the inhibition of nuclear factor-κB. J Immunol 159:5661, 1997
30. Hill GR, Cooke KR, Teshima T, Crawford JM, Keith JC, Brinson YS, Bungard D, Ferrara JLM: Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation. J Clin Invest 102:115, 1998
31. Peterson RL, Bozza MM, Dorner AJ: Interleukin-11 induces intestinal epithelial growth arrest through effects on retinoblastoma protein phosphorylation. Am J Pathol 149:895, 1996
32. Dorner AJ, Goldman SJ, Keith JC Jr: Interleukin-11: Biologic activity and clinical studies. BioDrugs 8:418, 1997
33. Matsumoto M, Tamura M, Matsubara S, Matsuno T, Ono M, Yokotoa T: Mechanism of protective effect of recombinant human granulocyte colony stimulating factor (rG-CSF) on Pseudomonas infection. Microbiol Immunol 35:461, 1991
34. Zeni F, Freeman B, Natanson C: Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment. Crit Care Med 25:1095, 1997
35. Cairo MS, Plunkett JM, Nguyen A, Schendel P, van de Ven C: Effect of interleukin-11 with and without granulocyte colony stimulating factor on in vivo neonatal rat hematopoiesis: Induction of neonatal thrombocytosis by interleukin-11 and synergistic enhancement of neutrophilia by interleukin-11 + granulocyte colony stimulating factor. Pediatr Res 34:56, 1993
36. Waxman AB, Einarsson O, Seres T, Knickbein RG, Warshaw JB, Johnston R, Homer RJ, Elias JA: Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminshes hyperoxia DNA fragmentation. J Clin Invest 101:1970, 1998